Venture Capital

Updated:

Serpentine Ventures

Serpentine Ventures is a Swiss venture asset manager. As entrepreneurs and investors they leverage experience from many highs and lows to support founders and...

Serpentine Ventures logo

Serpentine Ventures

Serpentine Ventures is a Swiss venture asset manager. As entrepreneurs and investors they leverage experience from many highs and lows to support founders and investors daily. They are constantly looking for new founding teams to invest in and support, and have funded more than 50 companies.

General information

Firm type

Venture Capital

Year founded

2019

Location

Region

Europe

Country

Switzerland

City

Zurich

Corporate office

Förrlibuckstrasse 190, 8005 Zurich, Switzerland

Principals

Oliver Walzer

Founding Partner & COO

Craig Cooper

Partner

Michael Stucky

Partner

Sector focus

Enterprise SoftwareAI/MLClimateTechDigital HealthAgriTech & FoodTechPropTechIndustrial TechMobility & TransportationEdTechRobotics & AutomationInsurTechCybersecurity

Frequently asked questions

Who runs investment decisions at Serpentine Ventures?

Oliver Walzer is the Founding Partner and COO, and he operates alongside partners Craig Cooper and Michael Stucky. The firm does not publicly detail a separate investment committee structure. Day-to-day investment decisions appear led by this small partnership group.

How does Serpentine Ventures source proprietary deal flow?

Serpentine emphasizes early conviction, investing in companies before incorporation in some cases—MindMetrix is cited as an example. The firm states it evaluates thousands of pitchdecks and entrepreneur meetings to sharpen instincts. Specific sourcing channels beyond its Swiss network are not publicly described.

What investment stages does Serpentine Ventures target?

Serpentine invests across the lifecycle: pre-seed (before incorporation), seed, start-up, early stage, expansion/late stage, and growth. It also executes PIPEs and spin-off transactions. The portfolio includes companies at every stage from pre-launch to Series A and beyond.

What is Serpentine Ventures' posture on co-investments alongside external GPs?

Serpentine co-invests alongside other venture capital firms as standard practice. In the Luna Health Series A, it invested alongside lead Vensana Capital. RAAAM's round was led by NXP Semiconductors with Serpentine participating as an existing investor. The firm does not advertise a formal co-investment program for limited partners.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Zurich Venture Capital profiles